ArticleOncotarget2017

Biological characterization of SN32976, a selective inhibitor of PI3K and mTOR with preferential activity to PI3Kα, in comparison to established pan PI3K inhibitors.

Gordon W Rewcastle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.